David D. Allison - Jun 16, 2023 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC (IMPL)

Role
Director
Signature
/s/ John Hoekman, Ph.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Jun 16, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 06:36 PM
Previous filing
Feb 24, 2023
Next filing
Apr 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +13.2K $0.00 13.2K Jun 16, 2023 Common Stock 13.2K $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested on June 16, 2024.